9024:TSESeibu Holdings, Inc. Analysis
Data as of 2026-03-14 - not real-time
¥4,154.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Seibu Holdings (9024.T) is trading at ¥4,154, well below its 20‑day (¥4,435) and 50‑day (¥4,328) simple moving averages, indicating a short‑term downtrend, while the 14‑day RSI of 35.9 suggests the stock is approaching oversold territory. The MACD histogram remains deeply negative (‑50.8) and the MACD signal is bearish, reinforcing downside momentum, yet the price sits near a key support level around ¥4,042 and volume has been decreasing, pointing to waning buying interest. On the valuation side, the trailing PE of 5.75 is dramatically lower than the industry average of 29.1, and the price‑to‑book of 1.94 implies a discount relative to book value, but the forward PE jumps to 29.5, reflecting a steep earnings decline forecast. Recent nine‑month results show net income falling from ¥91.36 B to ¥32.09 B, underscoring earnings pressure that drives the forward EPS downgrade from ¥722 to ¥141.
The balance sheet is heavily leveraged with a debt‑to‑equity of 118.6% and net debt far exceeding cash reserves, though the company generates robust ROE (42%) and profit margins (21.9%). Dividend yield sits at 0.96% with a modest payout ratio of 6.2%, suggesting sustainability despite cash‑flow reporting anomalies. Volatility is high at 27% over 30 days, but beta remains low (≈0.3), indicating limited market‑wide correlation. Overall, the stock appears undervalued from a value perspective but carries medium‑to‑high financial and operational risk.
The balance sheet is heavily leveraged with a debt‑to‑equity of 118.6% and net debt far exceeding cash reserves, though the company generates robust ROE (42%) and profit margins (21.9%). Dividend yield sits at 0.96% with a modest payout ratio of 6.2%, suggesting sustainability despite cash‑flow reporting anomalies. Volatility is high at 27% over 30 days, but beta remains low (≈0.3), indicating limited market‑wide correlation. Overall, the stock appears undervalued from a value perspective but carries medium‑to‑high financial and operational risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above the identified support level (¥4,042)
- Bearish MACD and decreasing trading volume
- RSI indicating potential oversold condition
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap (PE 5.75 vs industry 29.1)
- Low dividend payout ratio supporting cash return sustainability
- Target median price (~¥4,600) offering upside potential
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High ROE (42%) and strong profit margins
- Stable dividend yield with ample earnings coverage
- Low market beta suggesting defensive characteristics in a diversified portfolio
Key Metrics & Analysis
Financial Health
Revenue Growth-0.10%
Profit Margin21.90%
P/E Ratio5.8
ROE42.20%
ROA10.87%
Debt/Equity118.58
P/B Ratio1.9
Industry P/E29.1
Technical Analysis
TrendNeutral
RSI35.9
Support¥4,042.00
Resistance¥4,775.00
MA 20¥4,435.55
MA 50¥4,327.90
MA 200¥4,740.30
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Target Price¥4,070.00
Upside/Downside-2.02%
GradeUndervalued
TypeValue
Dividend Yield0.96%
Risk Assessment
Beta0.29
Volatility27.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.